Current Developments in the Pyran-Based Analogues as Anticancer Agents.

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Heterocyclic compounds are crucial for novel drug discovery, particularly for cancer treatment.
• Oxygen-containing heterocycles, especially pyran derivatives, exhibit significant pharmacological activities.
• Pyran, a six-membered oxygen-containing ring, is a privileged structure with diverse biological properties.

Purpose of the Study:

• To review recent advancements in pyran-based derivatives as anti-cancer agents.
• To consolidate research on the anti-cancer potential of various pyran structures.
• To highlight the therapeutic promise of pyran scaffolds in oncology.

Main Methods:

• Comprehensive literature review of pyran derivatives in cancer research.
• Analysis of in vitro (cell-based) and in vivo (animal-based) studies.
• Inclusion of molecular docking studies and natural pyran-containing anticancer compounds.

Main Results:

• Pyran derivatives demonstrate broad-spectrum anti-cancer properties against diverse cancer types.
• Evidence from in vitro, in vivo, and computational studies supports their efficacy.
• Natural compounds incorporating pyran structures also exhibit anti-cancer activity.

Conclusions:

• Pyran-based compounds represent a promising class of anti-cancer therapeutics.
• Further research into pyran derivatives can lead to novel cancer drug candidates.
• The privileged nature of the pyran scaffold facilitates the development of effective anti-cancer agents.